Statins research unfinished saga: desirability versus feasibility
<p>Abstract</p> <p>Drugs in the same class are generally thought to be therapeutically equivalent because of similar mechanisms of action (the so-called "class effect"). However, statins differ in multiple characteristics, including liver and renal metabolism, half-life,...
Main Authors: | Adler Yehuda, Fisman Enrique Z, Tenenbaum Alexander |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-06-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://www.cardiab.com/content/4/1/8 |
Similar Items
-
Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01) -
Statin efficacy in the treatment of hepatitis C genotype I
by: Ahmad Shavakhi, et al.
Published: (2014-01-01) -
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
by: Tenenbaum Alexander, et al.
Published: (2004-12-01) -
High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study
by: Lin TK, et al.
Published: (2018-01-01) -
Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01)